Moreover, LIFR reflects the chemosensitivity of metastatic CRC to cetuximab, which may be used to predict the susceptibility of individuals to cetuximab chemotherapy (Kim et al., 2011, 2013). Here, LIFR is linked to colorectal carcinoma.